Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · IEX Real-Time Price · USD
27.68
-1.07 (-3.72%)
At close: May 17, 2024, 4:00 PM
27.76
+0.08 (0.29%)
After-hours: May 17, 2024, 7:43 PM EDT
Dyne Therapeutics Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Dyne Therapeutics stock have an average target of 37.67, with a low estimate of 22 and a high estimate of 56. The average target predicts an increase of 36.09% from the current stock price of 27.68.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for DYN stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 5 | 5 | 5 |
| Buy | 2 | 2 | 1 | 3 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 4 | 8 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $31 | Strong Buy | Maintains | $31 | +11.99% | May 6, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $47 | Buy | Reiterates | $47 | +69.80% | May 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +30.06% | May 3, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $40 | Buy | Initiates | $40 | +44.51% | Apr 30, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $47 | Buy | Reiterates | $47 | +69.80% | Mar 26, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
27.09M
EPS This Year
-3.33
from -3.95
EPS Next Year
-3.31
from -3.33
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | 110.3M | 224.2M | 343.2M | 722.2M |
| Avg | n/a | 27.1M | 113.5M | 211.9M | 547.5M |
| Low | n/a | n/a | 10.9M | 108.7M | 436.3M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | 727.9% | 202.5% | 240.8% |
| Avg | - | - | 318.9% | 86.8% | 158.4% |
| Low | - | - | -59.8% | -4.2% | 105.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.96 | -2.30 | -1.12 | 0.07 | 1.43 |
| Avg | -3.33 | -3.31 | -2.77 | -1.30 | 0.46 |
| Low | -3.53 | -4.39 | -4.09 | -2.60 | -0.44 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.